Skip to content
PharmaManufacturingIQ

End-to end solution for continuous production of drug implants

We sit down with Dirk Leister, technical marketing manager, Thermo Fisher Scientific, to find out more about hot melt extrusion and the company’s new automated, integrated system designed for continuous production of drug implants.

By Dirk Leister
End-to end solution for continuous production of drug implants
Published: | 3 min read
Share to X Share to Bluesky Share to Facebook Share to LinkedIn Share by email

We sit down with Dirk Leister, technical marketing manager, process and pharma extruders for Thermo Fisher Scientific, to find out more about hot melt extrusion and the company’s new automated, integrated system designed for continuous production of drug implants.

End-to-end

Q. What is hot melt extrusion (HME) in a nutshell?

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information